ISG15‐Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans
Type I interferon (IFN) signalling induces the expression of several hundred IFN-stimulated genes (ISGs) that provide an unfavourable environment for viral replication. To prevent an overexuberant response and autoinflammatory disease, IFN signalling requires tight control. One critical regulator is the ubiquitin-like protein IFN-stimulated gene 15 (ISG15), evidenced by autoinflammatory disease in patients with inherited ISG15 deficiencies. Current models suggest that ISG15 stabilises ubiquitin-specific peptidase 18 (USP18), a well-established negative regulator of IFN signalling. USP18 also functions as an ISG15-specific peptidase that cleaves ISG15 from ISGylated proteins; however, USP18's catalytic activity is dispensable for controlling IFN signalling. Here, we show that the ISG15-dependent stabilisation of USP18 involves hydrophobic interactions reliant on tryptophan 123 (W123) in ISG15. Nonetheless, while USP18 stabilisation is necessary, it is not sufficient for the regulation of IFN signalling; ISG15 C-terminal mutants with significantly reduced affinity still stabilised USP18, yet the magnitude of signalling resembled ISG15-deficient cells. Hence, USP18 requires non-covalent interactions with the ISG15 C-terminal diGlycine motif to promote its regulatory function. It shows ISG15 is a repressor of type I IFN signalling beyond its role as a USP18 stabiliser.
Authors
- Kirby N. Swatek (ORCID: https://orcid.org/0000-0003-0634-3592)
- Michael P. Weekes (ORCID: https://orcid.org/0000-0003-3196-5545)
- J. Andrejeva
- Connor Bamford (ORCID: https://orcid.org/0000-0003-4895-1983)
- James Benedict Rowe (ORCID: https://orcid.org/0000-0001-7216-8679)
- John McLauchlan (ORCID: https://orcid.org/0000-0003-2217-9948)
- Dusan Bogunovic (ORCID: https://orcid.org/0000-0002-9277-3232)
- Ulrich Schwarz‐Linek (ORCID: https://orcid.org/0000-0003-0526-223X)
- David J. Hughes (ORCID: https://orcid.org/0000-0002-0090-5710)
- Andri Vasou (ORCID: https://orcid.org/0000-0003-4051-4658)
- Katie Nightingale (ORCID: https://orcid.org/0000-0001-9958-4699)
- Richard E. Randall (ORCID: https://orcid.org/0000-0002-9304-6678)
- Vladimíra Cetkovská
- Jonathan Scheler
Institutions
- University of St Andrews (GB)
- University of Dundee (GB)
- University of Cambridge (GB)
- Columbia University Irving Medical Center (US)
- MRC Protein Phosphorylation and Ubiquitylation Unit (GB)
- MRC University of Glasgow Centre for Virus Research (GB)
- Medical Research Council (GB)
Publication Details
- Journal
- European Journal of Immunology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/eji.202451651
- Citations
- 8
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 6.38
Funders
- University of Dundee
- Wellcome Trust
- Academy of Medical Sciences
- University of St Andrews
- Lister Institute of Preventive Medicine
- Medical Research Council